Editor's Note: A research team led by the University of Singapore has developed an artificial intelligence (AI) platform called, “IDentif.AI” (Indentifying Infectious Disease Combination Therapy with Artificial Intelligence) to increase efficiency in the development of treatments that combine several different drugs. The researchers selected 12 drugs that are viable candidates…
Editor's Note: Epic’s deterioration index, an artificial intelligence (AI), machine learning-based system that can predict which patients with COVID-19 could become seriously ill, has been put into use at hospitals nationwide, the April 24 STAT reports. Though normally hospitals would take weeks or months to test a new tool on…
Editor's Note Israel-based Scentech Medical and Meir Medical Center will start a trial of Scentech’s breath technology, which is designed to detect COVID-19 before it becomes symptomatic, the April 22 Times of Israel reports. The breath test technology—similar to breathalyzers used on suspected drunk drivers—is a mix of software and…
Editor's Note Among the actions announced April 15 by the Food & Drug Administration (FDA) in response to the COVID-19 pandemic are: Issuance of two new emergency use authorizations (EUAs) for serology tests, to detect for presence of coronavirus antibodies, to Ortho-Clinical Diagnostics, Inc, and Chembio Diagnostic systems, Inc. Issuance…
Editor's Note In this experimental study from Australia, researchers investigate the effect of ventilator splitting on system variables (ie, inspiratory pressure, flow, and volume) and the possibility of different ventilation targets for each limb. Connecting two patients to the same ventilator presents many challenges: ventilation requirements are different for different…
Editor's Note Safe Flight Instrument Corporation (White Plains, New York), a company that develops aircraft safety and performance technology, has developed the Quad/Vent Splitter that allows four patients to use one ventilator simultaneously, the April 13 Aviation International News Online reports. Using 3-D printing, the device has four independent ports…
Editor's Note The Food & Drug Administration (FDA) on April 7 issued an update on actions the agency has taken in its ongoing response to the COVID-19 pandemic. The actions include: a guidance for remote ophthalmic assessment and monitoring devices to facilitate patient care while reducing patient and healthcare provider…
Editor's Note During the first 3 weeks of the COVID-19 outbreak in the Seattle area, the most common reasons for ICU admission were hypoxemic respiratory failure leading to mechanical ventilation and/or hypotension requiring vasopressor treatment, and mortality was high in these critically ill patients, this study finds. In this analysis…
Editor's Note In this study, researchers from NYU Grossman School of Medicine and the Courant Institute of Mathematical Sciences at New York University, in partnership with Wenzhou Central Hospital and Cangnan People’s Hospital in Wenzhou, China, developed an artificial intelligence (AI) framework that accurately predicted which patients newly infected with…
Editor's Note The Food & Drug Administration (FDA) on March 24 took action to increase US supplies in response to the COVID-19 pandemic by providing instructions to manufacturers importing personal protective equipment (PPE) and other devices. The instructions to manufacturers clarify the types of PPE and devices they can import…